Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

EASD 2026 28 September - 2 October 2026

Efficacy of subcutaneous once-weekly semaglutide in recently diagnosed type 2 diabetes participants: An individual-level, pooled analysis of SUSTAIN trials

Authors :

Concetta Irace¹; Anna Areovimata²; Filipe Cortes-Figueiredo²; Bharath Kumar³; Nikolaos Tentolouris⁴

Affiliations

View Details Hide Details

Download poster (.pdf)

Keywords

Diabetes

Congress short oral presentation

GLP-1 RA

Semaglutide

Clinical